Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
... Schwartz ... BACKGROUND Most patients with acute coronary syndrome (ACS) are treated with statins, which reduce atherogenic triglyceride- ... Fasting triglycerides at initial random assignment were related to risk of coronary heart disease death, nonfatal myocardial ... Myocardial Ischemia Reduction with Acute Cholesterol Lowering) trial, respectively. Analysis of dal-OUTCOMES included 15,817 ...http://liu.diva-portal.org/smash/record.jsf?pid=diva2:825326
Abstract 2216: Polyvascular Disease - A Novel Risk Factor for Worse Ischemic and Bleeding Outcomes in Acute Coronary Syndromes ...
Fondaparinux is Similar to Enoxaparin in Preventing Ischemic Events Among Patients with Acute Coronary Syndromes but Causes...
Fondaparinux is Similar to Enoxaparin in Preventing Ischemic Events Among Patients with Acute Coronary Syndromes but Causes ... coronary procedures reduce ischemic coronary events in patients with acute coronary syndromes, but increase bleeding. ... Fondaparinux is Similar to Enoxaparin in Preventing Ischemic Events Among Patients with Acute Coronary Syndromes but Causes ... Enoxaparin is a low molecular weight heparin commonly used in patients with acute coronary syndromes that reduces their risk of ...http://www.cardiologyonline.com/journal_articles/Fondaparinux.htm
Abstract 15029: Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient...
Background: Despite current therapy, patients with acute coronary syndrome (ACS) and history of stroke or transient ischemic ... Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: ... Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: ... Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndromes and History of Stroke or Transient Ischemic Accident: ...http://circ.ahajournals.org/content/124/Suppl_21/A15029
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome |...
Role of optimal medication given to patients with hypertension and ischemic heart disease prior to an acute coronary syndrome. ... Keywords: Acute coronary syndrome, Cardiac mortality, Hypertension, Ischemic heart disease, Optimal cardio - vascular ... Keywords: Acute coronary syndrome, Cardiac mortality, Hypertension, Ischemic heart disease, Optimal cardio - vascular ... who developed a first episode of acute coronary syndrome (ACS). Methods. The study was carried out retrospectively and included ...http://www.touchcardio.com/articles/role-optimal-medication-given-patients-hypertension-and-ischemic-heart-disease-prior-acute
The electrocardiographic differential diagnosis of ST segment depression | Emergency Medicine Journal
Acute coronary ischaemic syndromes. Acute coronary ischaemia (non-infarction). STD attributable to ischaemia is often diffuse ... Non-acute coronary ischaemic syndrome causes of ST segment depression. Intraventricular conduction disorders. Intraventricular ... STD is associated with acute coronary syndromes (ACS)-both acute ischaemia and acute infarction; this electrocardiographic ... The types of ST segment depression in the patient with acute coronary ischaemic syndrome and no evidence of infarction. (A) ...http://emj.bmj.com/content/19/2/129.full
Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized...
Acute Coronary Syndromes Cardiology Clinical Pharmacy and Pharmacology Headache Heart Failure Health Care Safety Ischemic Heart ... Ongoing exploration of cell-based therapy for ischemic cardiomyopathy is warranted.. Although cell therapy for acute MI has ... remodeling with acute4,7 myocardial infarction (MI) and chronic1-3,5,8,9 ischemic cardiomyopathy. An effective antiremodeling, ... Cell therapy offers promise for treating chronic ischemic heart disease,1-3,5,7,13,23-27 but safety and efficacy remain ...https://jamanetwork.com/journals/jama/fullarticle/1780025
Yearbook of Intensive Care and Emergency Medicine 1997 | Prof. Jean-Louis Vincent | Springer
Emergency Evaluation of Acute Ischemic Coronary Syndrome. Gibler, W. B. (et al.) ...https://www.springer.com/us/book/9783662134528?wt_mc=
Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive...
Power Thrombectomy in Acute Ischemic Coronary Syndromes. Topaz, On; Perin, Emerson C.; Jesse, Robert L.; Mohanty, Pramod K.; ... Intracoronary thrombi are commonly found in patients with acute coronary syndromes. A large thrombus burden or a platelet-rich ... Iron and coronary heart disease. Burt, M.J.; Halliday, J.W.; Powell, L.W. // BMJ: British Medical Journal (International ... Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive ...http://connection.ebscohost.com/c/articles/36959867/immediate-improvement-coronary-flow-reserve-after-alcohol-septal-ablation-patients-hypertrophic-obstructive-cardiomyopathy
The Evaluation of Chest Pain in the Emergency Setting - Brown Flashcards by Amanda Kroymann | Brainscape
Ischemic Heart Disease/Acute Coronary Syndrome. * thrombolytic therapy. * cardiac cath. Other cardiac or pulmonary problems ... Describe the classification of Acute Coronary Syndrome and the inital evaluation based upon 12-lead ECG findings ... Describe the classification of Acute Coronary Syndrome and the inital evaluation based upon 12-lead ECG findings ... Describe the classification of Acute Coronary Syndrome and the inital evaluation based upon 12-lead ECG findings ...https://www.brainscape.com/flashcards/the-evaluation-of-chest-pain-in-the-emerg-1957192/packs/3579975
Blood Brain Barrier Opening in Alzheimer' Disease - Full Text View - ClinicalTrials.gov
recent acute coronary syndrome or unstable ischemic heart disease. *heart failure, chronic or acute stage III or IV, ... Ischemic or haemorrhagic stroke consisting of supracentimetric vascular leucopathy with a grade greater than 2 in the ... Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/ ... Patient with an ongoing infection clinically characterized by febrile syndrome and possible calling points (cough, pain, skin ...https://clinicaltrials.gov/ct2/show/study/NCT03119961?show_desc=Y
Percutaneous transluminal coronary angioplasty in unstable angina: comparison with stable angina. - Semantic Scholar
Twenty eight of 32 successfully treated patients were followed up by means of repeat coronary arteriography, exercise ... Percutaneous transluminal coronary angioplasty was performed in 25 patients with unstable angina and in a similar group of 25 ... Indications for coronary angioplasty in acute myocardial ischemic syndromes. *Pim J. de Feyter, Patrick W. Serruys, Paul G. ... for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes ...https://www.semanticscholar.org/paper/Percutaneous-transluminal-coronary-angioplasty-in-Quigley-Erwin/f61290326f3ae5fdfed9358bdac3400269d93110
Abstract 17948: In-vivo Visualization of Increased and Persistent Vascular Lipid Deposition by Nirs and Ivus Predicts...
Introduction: Thin-cap fibroatheromas are the pathologic cause of acute coronary syndromes and ischemic sudden death. Near ... Methods: Multi-vessel coronary angiography, IVUS and NIRS were performed 3, 6 and 9 months (m) after induction of diabetes (DM ... Five animals died of ischemic sudden death and 3 of other causes. The remaining animals were sacrificed at 9-m. ... Core 6. Catheter-Based and Surgical InterventionsSession Title: Coronary Pathobiology. Abstract 17948: In-vivo Visualization of ...http://circ.ahajournals.org/content/124/Suppl_21/A17948
Effects of fluid dynamic shear stress on platelet aggregability under pathophysiologic conditions
Increased plasma catecholamine concentrations have also been implicated in the onset of acute coronary ischemic syndromes. This ...https://scholarship.rice.edu/handle/1911/19227
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency - Full Text View -...
Acute myocardial infarction, acute coronary syndrome, transient ischemic attack, or stroke within 3 months of enrollment. ... Assessment must be performed at least 12 weeks after major cardiac surgical intervention including coronary artery bypass graft ...https://clinicaltrials.gov/ct2/show/study/NCT03037931
Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging-Monitored Therapy |...
Effect of atorvastatin on early recurrent ischemic events in acute coronary syndromes. JAMA. 2001; 285: 1711-1718. ... Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes. JAMA. 2003; 290: ... Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS ... explain the salutary effects of statin therapy in terms of clinical outcomes 16 weeks after an index acute coronary syndrome, ...http://circ.ahajournals.org/content/110/16/2336
Response to Letter by Xu and Liu | Stroke
Risk factors comparison in Chinese developing acute coronary syndrome, ischemic or hemorrhagic stroke: a multi-provincial ... Table 2. The Relative Risk (RR) of Ten Year Incidence Rates of Acute Ischemic Stroke and Acute Hemorrhagic Stroke in Chinese ... Trend analyses in the incidence of acute intracerebral hemorrhagic events and acute cerebral infarction events in urban area in ... Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged Chinese. Am J Cardiol. 2007; ...http://stroke.ahajournals.org/content/39/7/e104
Pharmacotherapy casebook : a patient-focused approach (Book, 2005) [WorldCat.org]
Ischemic heart disease and acute coronary syndrome / Shawn R. Hansen and Amy J. Guenette --. Ch. 12. Acute myocardial ... Drug-induced acute renal failure / Mary K. Stamatakis --. Ch. 48. Acute renal failure / Reina Bendayan and Michelle D. Furler ... Acute asthma / Tia D. Eddy, Daniel T. Kennedy and Ralph E. Small --. Ch. 25. Chronic asthma / Dennis M. Williams --. Ch. 26. ... Acute pancreatitis / Charles W. Felrow and Maria B. Yaramus --. Ch. 43. Chronic pancreatitis / Susan D. Bear and Donna S. Wall ...http://www.worldcat.org/title/pharmacotherapy-casebook-a-patient-focused-approach/oclc/57010413
Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease - Full Text View -...
Lack of known cardiovascular disease (coronary acute syndrome, stable ischemic cardiopathy, peripheric arteriopathy and ... Stable patients who coronary syndrome, cerebrovascular accident or peripheric arteriopathy event occurred at least 6 months or ...https://clinicaltrials.gov/ct2/show/NCT01449110?term=resveratrol&rank=7
Arginylglycylaspartic acid - Wikipedia
Eptifibatide and tirofiban are anti-clotting drugs indicated to prevent thrombosis in acute ischemic coronary syndromes. They ... Kloner, Robert A. (2013-08-02). "Current State of Clinical Translation of Cardioprotective Agents for Acute Myocardial ...https://en.wikipedia.org/wiki/Arginylglycylaspartic_acid
Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF) - Full Text View - ClinicalTrials.gov
Acute myocardial infarction or acute coronary syndrome, transient ischaemic attack or stroke within the last 3 months. ... Coronary-artery bypass graft, percutaneous intervention (e.g. cardiac, cerebrovascular, aortic; diagnostic catheters are ...https://clinicaltrials.gov/ct2/show/NCT00520780?term=iron-deficiency+anemia&rank=12
Cardiac Literature, including Myocardial Infarction, arrthymias, tachycardia, and angina sub-cluster 33
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and ... ... Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: ... ... the risk of recurrent ischemic complications in patients with non-ST-elevation acute coronary syndromes (NSTE-ACSs) remains ... molecular-weight heparin enoxaparin has been shown to decrease ischemic complications in patients with acute coronary syndromes ...http://www.biomedsearch.com/cluster/1/Cardiac-Literature-including-Myocardial-Infarction-arrthymias-tachycardia-and-angina/sub-33-p8.html
A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately...
Myocardial infarction, acute coronary syndrome, or transient ischemic attack/stroke within 6 months prior to screening ... Acute metabolic diabetic complications such as ketoacidosis or hyperosmolar coma within the past 6 months ...https://clinicaltrials.gov/ct2/show/NCT01729403?recr=Open&cond=%22Diabetes+Mellitus%2C+Type+2%22&rank=13
Inhibition of the Plasma SCUBE1, a Novel Platelet Adhesive Protein, Protects Mice Against ThrombosisSignificance |...
... within the range of elevated plasma SCUBE1 levels observed in patients experiencing acute coronary syndrome or acute ischemic ... Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic ... is significantly elevated and is a potential biomarker of platelet activation in acute coronary syndrome and acute ischemic ... Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation. 2002;105:2166-2171. ...http://atvb.ahajournals.org/content/34/7/1390